COMPANY
Altaire Pharmaceuticals, Inc.
Altaire Pharmaceuticals, Inc.: recalling firm for Bacitracin, as stated by public registers.
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Bacitracin | Class II recall, Completed, 2019-11-27 Regulator openFDA |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.